Global PharmaPartners, Inc (GPP) was founded in 2006 by Rob Camerer. Bringing high value pharmaceutical developments (HVPD) from Europe to the USA and Canada - licensing these HVPD's to world class pharmaceutical customers, ever expanding our product portfolio and our customer base. GPP acquires and licenses pharmaceutical dossiers from top US, EU and Global development pharma companies. Through time, GPP has created significant business $USD for our global development partners with license fees in excess of $50 million USD and revenues in the coming years to reach over $1 Billion USD. Since 2006, GPP has signed partnerships with many pharma development companies focusing on the top echelon of pharma. Experiencing significant success in licensing these pharma products into all of North America, GPP has built a reputation by capitalizing on excellent international pharma developments and then negotiating and closing excellent licensing deals. Starting in 2006 with only 5 products, today GPP has access to and promotes over 1000 generic and branded pharmaceutical products and dossiers. GPP, a privately owned company, GPP has its headquarters in Springfield, Missouri. GPP has experience in product licensing in over 89 countries with a focus on the USA and Canada. GPP is experiencing growth and profitability year after year and is positioned to support both our development partners and our pharmaceutical customer base in the global markets with excellent products for today and the future.